References
- Robinson R. Limits to rationality: economics, economists and priority setting. Health Policy49, 13–26 (1999).
- Drummond M, Brown R, Fendrick AM et al. Use of pharmacoeconomics information – report of the ISPOR task force on use of pharmacoeconomic/health economic information in health-care decision making. Value Health6(4), 407–416 (2003).
- Zwart-van Rijkom JEF, Leufkens HGM, Busschbach JJV et al. Differences in attitudes, knowledge and use of economic evaluations in decision making in the Netherlands, Pharmacoeconomics18(2), 149–160 (2000).
- van Velden ME, Severens JL, Novak A. Economic evaluations of healthcare programmes and decision making: the influence of economic evaluations on different healthcare decision-making levels. Pharmacoeconomics23(11), 1075–1082 (2005).
- Eddama O, Coast J. A systematic review of the use of economic evaluation in local decision making. Health Policy86, 129–141 (2008).
- Hoffman C, Stoykova BA, Nixon BA et al. Do health care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities. Value Health5(2), 71–79 (2002).
- Williams I, Bryan S. Understanding the limited impact of economic evaluation in health care resource allocation: a conceptual framework. Health Policy80, 135–134 (2007).
- Willimans I, Bryan S. Cost–effectiveness analysis and formulary decision making in England: findings from research. Soc. Sci. Med.65(10), 2116–2129 (2007)
- van Gool K, Gallego G, Haas M, Viney R, Hall J, Ward R. Economic evidence at the local level: options for making it more useful. Pharmacoeconomics25(12), 1055–1062 (2007).